HDCN Hyperphosphatemia CME Info     

Hyperphosphatemia: Clinical Complications
and Management in 1998

University of Minnesota
CME Internet Course

Introduction

This CME Internet program provides an overview of clinical complications and management of hyperphosphatemia, a common complication in patients with kidney disease. Hyperphosphatemia is challenging to manage and is associated with secondary hyperparathyroidism, metastatic calcification, and renal bone disease. This symposium discusses current tools in phosphate control and presents new therapeutic approaches for treating hyperphosphatemia and managing its complications. The intended audience is nephrologists and other health professionals working with patients with kidney disease.

Program Objectives Include:

  • Provide an overview of the role of hyperphosphatemia in patient outcomes and discuss the importance of phosphorus control in managing clinical complications
  • Discuss current tools in phosphate management, such as diet, phosphate binders, and dialysis, and their limitations
  • Present emerging therapeutic approaches that hold promise in the treatment and management of hyperphosphatemia

Faculty

Eduardo Slatopolsky, MD
Professor of Renal Diseases in Medicine
Washington University, St. Louis, MO

Francisco Llach, MD
Chief of Nephrology
Beth Israel Medical Center, Newark, NJ

Jill Lindberg, MD
Director of Nephrology Research and Chronic Hemodialysis
Codirector of Metabolic Bone & Stone Clinic
Ochsner Clinic, New Orleans, LA

Earning CME Credit

This CME Internet program is sponsored by the University of Minnesota Medical School Office of Continuing Medical Education. The University of Minnesota is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This educational activity was planned and produced in accordance with the ACCME Essentials.

Date of original release: December 1998
Requests for CME credit must be received no later than December 30, 1999.
Estimated time of completion is 1.5 hours.

The University of Minnesota designates this educational activity for up to 1.5 hours in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit actually spent in the educational activity.

This program was presented as a satellite symposium at the 1998 American Society of Nephrology meeting in Philadelphia. Any physician who earned CME credits at this symposium is not eligible to receive CME credits for this Internet program.

This Internet program is supported by an unrestricted educational grant from Genzyme Therapeutics, and administered by Medical Education Institute.

To earn credit for viewing the lectures, please print out and complete the enrollment, evaluation, and posttest forms and mail them to:

University of Minnesota
Office of Continuing Medical Education
615 Washington Ave. SE
Suite 107
Minneapolis, MN 55414

or FAX to (612) 626-7766.

Forms Required to Earn CME Credits

Enrollment
Posttest
Evaluation

Additional Information

Selected References
Conflict of Interest, Trade Name, and Nonindicated Use Information

Back to list of talks for this symposium
Back to symposia list by topic
Back to symposia list by meeting
Back to HDCN home page


HDCN